Clinical Trial

Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study is a double-blind, randomized, prospective, placebo-controlled single-center clinical research study in which 600 mg of gabapentin or placebo will be administered 2 hours preoperatively to 49 patients each undergoing wisdom teeth extraction. We will measure intraoperative opioid use, severity of pain, the number of analgesics taken, and side effect profiles (e.g. nausea/vomiting, dizziness) at the following intervals, 4 hour, 8 hour, 12 hour, 24, and 72 hour post-procedure.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2021-04-22; most recent amendment 2026-02-02.
Status change: Not Yet Recruiting → Recruiting 2021-10-04
Trial Details
NCT Number NCT04860141
Lead Sponsor Loma Linda University
Conditions Dental Pain and Sensation Disorder, Pain, Postoperative
Enrollment 98 participants
Start Date 2021-06-16
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-04